1. Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancer
- Author
-
Bogda Koczwara, Amitesh Roy, Raghu Kumar, John Leung, Jeffrey Bowden, Tony Woo, Ganessan Kichenadasse, Shawgi Sukumaran, Gargi Surendra Patel, and Christos S. Karapetis
- Subjects
medicine.medical_specialty ,business.industry ,Pleural effusion ,Delayed onset ,Cancer ,medicine.disease ,respiratory tract diseases ,Concurrent chemoradiotherapy ,Surgery ,Internal Medicine ,medicine ,Non small cell ,Lung cancer ,Complication ,business ,Pathological - Abstract
Chronic benign pleural effusion (BPE) is a rare complication of concurrent chemoradiotherapy (CRT) for inoperable stage IIIA non-small-cell lung cancer (NSCLC). This report presents three cases of BPE, the workup to differentiate this benign condition from recurrence of cancer and recommends a pleural biopsy as part of the diagnostic process. These inflammatory exudates often remain indolent, and may not require drainage or surgical intervention. In the absence of clinical, radiological and pathological evidence of recurrent disease, we recommend clinicians manage these patients expectantly, using regular clinical assessment and imaging.
- Published
- 2015